Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study.
Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):105-114. doi: 10.1016/j.ijrobp.2023.03.042. Epub 2023 Mar 15.
Int J Radiat Oncol Biol Phys. 2023.
PMID: 36925073
Clinical Trial.
Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib.
Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, Alguayn F, Peled N, Roisman LC.
Kian W, et al. Among authors: krayim b.
Front Oncol. 2023 Feb 27;13:1124949. doi: 10.3389/fonc.2023.1124949. eCollection 2023.
Front Oncol. 2023.
PMID: 36923435
Free PMC article.
Item in Clipboard
An Unusual Presentation of HCC in a Patient with No Underlying Liver Disease: A Case Study.
Osyntsov A, Zemel M, Cohen N, Cooper JM, Krenawi M, Krayim B, Kian W, Marei R, Shalata W, Sebbag G, Abu-Swis S.
Osyntsov A, et al. Among authors: krayim b.
Case Rep Oncol. 2022 Nov 8;15(3):995-1000. doi: 10.1159/000526929. eCollection 2022 Sep-Dec.
Case Rep Oncol. 2022.
PMID: 36636683
Free PMC article.
Item in Clipboard
Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Kian W, Christopoulos P, Remilah AA, Levison E, Dudnik E, Shalata W, Krayim B, Marei R, Yakobson A, Faehling M, Kahala D, Sara Granot I, Levitas D, Peled N, Roisman LC.
Kian W, et al. Among authors: krayim b.
Front Oncol. 2022 Sep 20;12:1010311. doi: 10.3389/fonc.2022.1010311. eCollection 2022.
Front Oncol. 2022.
PMID: 36203432
Free PMC article.
Item in Clipboard
Cite
Cite